These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6846326)

  • 81. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.
    Hogg PJ; Jackson CM
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3619-23. PubMed ID: 2726739
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Protamine complexes with antithrombin III and heparin].
    Roszkowska W; Worowski K
    Acta Haematol Pol; 1982; 13(1-2):25-8. PubMed ID: 7180353
    [No Abstract]   [Full Text] [Related]  

  • 84. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III.
    Schoen P; Wielders S; Petitou M; Lindhout T
    Thromb Res; 1990 Feb; 57(3):415-23. PubMed ID: 2315894
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Thrombin interaction with fibrin polymerization sites.
    Hsieh K
    Thromb Res; 1997 May; 86(4):301-16. PubMed ID: 9187018
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Interaction of the sulfated lactobionic acid amide LW 10082 with thrombin and its endogenous inhibitors.
    Klauser RJ
    Thromb Res; 1991 Jun; 62(5):557-65. PubMed ID: 1896968
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Precipitation and Neutralization of Heparin from Different Sources by Protamine Sulfate.
    Hogwood J; Mulloy B; Gray E
    Pharmaceuticals (Basel); 2017 Jul; 10(3):. PubMed ID: 28671597
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Ternary vitronectin-thrombin-antithrombin III complexes in human plasma. Detection and mode of association.
    de Boer HC; de Groot PG; Bouma BN; Preissner KT
    J Biol Chem; 1993 Jan; 268(2):1279-83. PubMed ID: 7678252
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Antithrombin III-beta associates more readily than antithrombin III-alpha with uninjured and de-endothelialized aortic wall in vitro and in vivo.
    Witmer MR; Hatton MW
    Arterioscler Thromb; 1991; 11(3):530-9. PubMed ID: 2029494
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Reaction of antithrombin III with thrombin bound to the vascular endothelium. Analysis in a recirculating perfused rabbit heart preparation.
    Lollar P; MacIntosh SC; Owen WG
    J Biol Chem; 1984 Apr; 259(7):4335-8. PubMed ID: 6707006
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Histidine-rich glycoprotein does not interfere with interactions between antithrombin III and heparin-like compounds on vascular endothelial cells.
    Shimada K; Kawamoto A; Matsubayashi K; Ozawa T
    Blood; 1989 Jan; 73(1):191-3. PubMed ID: 2910359
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Thrombin inhibition by antithrombin III on the subendothelium is explained by the isoform AT beta.
    Frebelius S; Isaksson S; Swedenborg J
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1292-7. PubMed ID: 8857927
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A heparin-like anticoagulant in an 8-month-old boy with acute monoblastic leukemia.
    Bussel JB; Steinherz PG; Miller DR; Hilgartner MW
    Am J Hematol; 1984 Jan; 16(1):83-90. PubMed ID: 6582779
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA.
    Kalathottukaren MT; Abraham L; Kapopara PR; Lai BF; Shenoi RA; Rosell FI; Conway EM; Pryzdial EL; Morrissey JH; Haynes CA; Kizhakkedathu JN
    Blood; 2017 Mar; 129(10):1368-1379. PubMed ID: 28034889
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Determination of soluble fibrin by turbidimetry of its protamine sulphate-induced paracoagulation.
    Wieding JU; Eisinger G; Köstering H
    J Clin Chem Clin Biochem; 1989 Feb; 27(2):57-63. PubMed ID: 2746164
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A study of the large heparin requirements in the generalized Shwartzman reaction.
    Gurewich V; Lipinski B; Wetmore R
    Blood; 1976 Feb; 47(2):297-304. PubMed ID: 1244924
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Coagulation parameters and heparin levels in open-heart surgery.
    Cullmann W; Müller N; Lie TB; Kladetzky RG; Jürgens P
    Res Exp Med (Berl); 1980; 177(2):111-7. PubMed ID: 7444168
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effect of protamine sulfate in neutralizing coagulation defect produced by paritol.
    BARTHOLOMEW LG; BARKER NW
    Proc Soc Exp Biol Med; 1952 Nov; 81(2):339-41. PubMed ID: 13027299
    [No Abstract]   [Full Text] [Related]  

  • 100. Ultrasonic detection of red cell aggregation immediately preceding blood clotting.
    Sigel B; Machi J; Beitler JC; Ramos JR; Justin JR; Feinberg H
    Invest Radiol; 1984; 19(5):458-61. PubMed ID: 6511252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.